The Star Ratings Shakeup: Court Challenges CMS Measure Authority
The Clover vs. CMS litigation could significantly reshape how Medicare Advantage Star Ratings are measured, governed, and challenged.
On May 27, a federal court ordered CMS to recalculate Clover's 2026 star rating, days before bids were due. The difference from the SCAN, Elevance, and Humana cases: Clover challenged whether CMS can even use certain measures, including one run by a private contractor — a theory that could open a new line of challenge as CMS overhauls the program in the 2027 final rule.
Join RISE and industry experts for a fast-moving, tactical discussion on what Medicare Advantage plans should be doing now to assess risk, adapt Stars strategies, and prepare for potential regulatory changes, with extended interactive Q&A focused on real-world operational challenges.
Join us for this complimentary webinar to:
- Assess which Star Ratings measures and methodologies may face increased scrutiny or change
- Understand the operational, compliance, and financial implications for MA organizations
- Prepare quality, Stars, compliance, and member engagement teams for potential audit and reporting shifts
- Participate in closed-door Q&A with industry leaders
